title: The U.S. Food and Drug Administration announcement suggests the need to revisit guidelines for antibiotic use after EUS-FNA.
authors.affiliation: Center for Digestive Diseases, Sanford Medical Center, Fargo, North Dakota, USA; Department of Medicine, University of North Dakota School of Medicine, Grand Forks, North Dakota, USA.
authors.forename: Navin
authors.initials: N
authors.lastname: Paul
mesh_terms: D019980:Amoxicillin-Potassium Clavulanate Combination / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000592:standards*; D061765:Endoscopic Ultrasound-Guided Fine Needle Aspiration / Q000592:standards*; D006801:Humans; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D011182:Postoperative Care / Q000592:standards*; D017410:Practice Guidelines as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000900:Anti-Bacterial Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D019980:Amoxicillin-Potassium Clavulanate Combination; D010397:Penicillanic Acid; D010878:Piperacillin